[ Price : $8.95]
Federal Register Notice: FDA seeks comments on its postmarket surveillance regulations.[ Price : $8.95]
Federal Register Notice: FDA requests nominations for consumer representatives to serve on various advisory committee.[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Pfizers Draxxin is 2,451 days.[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Scios Natrecor for the purpose of patent extension.[ Price : $8.95]
FDA approves two expanded indications for Genentechs Rituxan for patients with CD20-positive, B-cell non-Hodgkin's lymphoma.[ Price : $8.95]
CDRH director Daniel Schultz tells Congress that correctly reprocessed single use devices are as safe and effective as new devices...[ Price : $8.95]
FDA says GSKs Lamictal may cause cleft palate or cleft lip in babies whose mothers took the drug during the first trimester of pre...[ Price : $8.95]
FDA issues Labopharm an approvable letter for a once-daily formulation of tramadol, marketed by other companies as immediate-relea...